Aved Products Recall for Lack of Market Authorization
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Health Canada has issued a recall for several Aved ophthalmic products due to them being sold without market authorization in Canada.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on April 2, 2026 and geographically references Canada. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, ophthalmic-products.
What Happened
Health Canada has recalled Aved products because they were sold without market authorization (DIN) in Canada, due to third-party branding.
Which Products Are Affected
The affected products include:
- Labtician Ophthalmics, Inc. / Aved Atropine Sulfate 0.01% Ophthalmic Solution, 5 mL, with no market authorization, solution form, strength Atropine Sulfate 0.01%, lot numbers 11122025@5 and 01052026@11.
- Labtician Ophthalmics, Inc. / Aved Atropine Sulfate 0.02% Ophthalmic Solution, 5 mL, with no market authorization, solution form, strength Atropine Sulfate 0.02%, lot numbers 10162025@3, 12052025@5, and 01272026@13.
- Labtician Ophthalmics, Inc. / Aved Atropine Sulfate 0.025% Ophthalmic Solution, 5 mL, with no market authorization, solution form, strength Atropine Sulfate 0.025%, lot numbers 10162025@5, 12082025@12, 01272026@14, and 02252026@5.
- Labtician Ophthalmics, Inc. / Aved Atropine Sulfate 0.05% Ophthalmic Solution, 5 mL, with no market authorization, solution form, strength Atropine Sulfate 0.05%, lot numbers 10022025@3, 11202025@8, 01152026@6, and 02042026@14.
- Labtician Ophthalmics, Inc. / Aved Fluorescein Na 0.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 5 mL, with no market authorization, solution form, strength Fluorescein Na 0.25% / Proparacaine HCl 0.5%, lot numbers 11202025@5, 12082025@11, and 12232025@2. The recalling firm is Aved, located at 44 Richmond St. West, Unit 202, Oshawa, Ontario, L1G 1C7.
What You Should Do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects or other safety complaints to Health Canada.
Why This Matters
This recall addresses products that do not meet Canadian regulatory standards, potentially affecting their safety and efficacy for consumers.
Source
This information is from Health Canada, available at: https://recalls-rappels.canada.ca/en/alert-recall/aved-products-recall-no-market-authorization
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (2,124 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to April 2, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.